The following twelve proposals were recommended for full funding by the Congressionally Directed Medical Research Program (CDMRP) integration panel in December. They were publicly announced at last week’s Research Advisory Committee (RAC-GWVI) meetings in Washington, DC.
While these twelve represent among the best of those proposed, our panel had a very challenging time selecting from among the many excellent proposals submitted.
Simply put, the panel could have funded quite a few additional and important treatment-focused studies had there been more funding available.
Future funding for the program will be especially important given that three “consortium” proposals were funded – essentially infrastructure building to enhance the collective efforts of a virtual “Who’s Who” of clinical and scientific researchers actively engaged in unlocking the keys to understanding and treating Gulf War Illness.
- Brain-Immune Interactions as the Basis of Gulf War Illness: Consortium Development. Boston University Medical Campus, Kimberly Sullivan
- Integrative Physiology of Gulf War Illness: Role of Autonomic Function, Central Neural Processing, and Sleep. Veterans Bio-Medical Research Institute, Inc., Jorge Serrador
- Gulf War Illness Research Development Consortium (GWIC). Wright State University, Mariana Morris
- Assessment of Diverse Biological Indicators in Gulf War Illness: Are They Replicable? Are They Related? Baylor University, Lea Steele
- Redefining Gulf War Illness Using Longitudinal Health Data: The Fort Devens Cohort. Boston VA Research Institute, Inc. (BVARI), Maxine Krengel
- Proteomic Immune Profiling for the Therapeutic Modulation of Cognitive Impairment in a Novel GWI Mouse Model. Roskamp Institute, Ghania Ait-Ghezala
- Synergistic Actions of Pyridostigmine Bromide and Insecticides on Muscle and Vascular Nociceptors. University of Florida, Brian Cooper
- A Preliminary Trial of Repetitive Transcranial Magnetic Stimulation in Gulf War Veterans With Chronic Multisymptom Illness. VA Medical Center, Bronx, NY, Julia Golier
- Detection of Xenotropic Murine Leukemia Virus- Related Virus (XMRV) in Gulf War Illness: Role in Pathogenesis or Biomarker? Whittemore Peterson Institute, Judy Mikovits
- XMRV and GWI: Is There an Association? Yale University, Richard Sutton
- Investigating Clinical Benefits of a Novel Sleep-Focused, Mind-Body Program on Gulf War Illness Symptoms: An Exploratory Randomized Controlled Trial. University of Utah, Yoshio Nakamura
- Nasal Irrigation for Chronic Rhinosinusitis and Fatigue in Patients With Gulf War Syndrome. University of Wisconsin-Madison, David Rabago
“The [above] list of FY2010 Gulf War Illness Research Program awards represent applications recommended for funding and is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.”
CDMRP on GWI: Gulf War Illness (GWI) is characterized by persistent symptoms such as chronic headache, widespread pain, cognitive difficulties, unexplained fatigue, gastrointestinal problems, respiratory symptoms, and other abnormalities that are not explained by traditional medical or psychiatric diagnoses.
This complex set of chronic symptoms may affect as many as 200,000 veterans of the 1990-1991 Gulf War, of the over 700,000 deployed to that region.
The GWIRP focuses its funding on innovative projects that have the potential to make a significant impact on GWI, improving the health and lives of affected service members and their families.
Program Vision: Improve the health and lives of veterans who have Gulf War Illness.
Program Mission: Fund innovative Gulf War Illness research to identify effective treatments, improve definition and diagnosis, and better understand pathobiology and symptoms.